Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Renal Fanconi syndrome: taking a proximal look at the nephron.

Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockenhauer D.

Nephrol Dial Transplant. 2014 Dec 9. pii: gfu377. [Epub ahead of print] Review.

PMID:
25492894
2.

Sodium glucose co-transporter 2 inhibitors and their mechanism for improving glycemia in patients with type 2 diabetes.

Davidson JA, Kuritzky L.

Postgrad Med. 2014 Oct;126(6):33-48. doi: 10.3810/pgm.2014.10.2819. Review.

PMID:
25414933
3.

Novel antiretroviral drugs and renal function monitoring of HIV patients.

Maggi P, Montinaro V, Mussini C, Di Biagio A, Bellagamba R, Bonfanti P, Calza L, Cherubini C, Corsi P, Gargiulo M, Montella F, Rusconi S.

AIDS Rev. 2014 Jul-Sep;16(3):144-51. Review.

PMID:
25102336
4.

Sodium glucose co-transporter 2 (SGLT2) inhibitors: new among antidiabetic drugs.

Opie LH.

Cardiovasc Drugs Ther. 2014 Aug;28(4):331-4. doi: 10.1007/s10557-014-6522-0. Review.

PMID:
24825435
5.

Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport.

Abdul-Ghani MA, DeFronzo RA.

J Intern Med. 2014 Oct;276(4):352-63. doi: 10.1111/joim.12244. Review.

PMID:
24690096
6.

Ifosfamide-induced Fanconi syndrome with diabetes insipidus.

Leem AY, Kim HS, Yoo BW, Kang BD, Kim MH, Rha SY, Kim HS.

Korean J Intern Med. 2014 Mar;29(2):246-9. doi: 10.3904/kjim.2014.29.2.246. Epub 2014 Feb 27. Review.

7.

Unusual manifestation of crystalline light chain tubulopathy in patient with multiple myeloma: case report and review of the literature.

Stompór T, Perkowska-Ptasińska A, Wojciechowska M, Zając K, Chmielewska-Badziąg A, Pawłowska A.

Ren Fail. 2014 Jun;36(5):795-9. doi: 10.3109/0886022X.2014.884446. Epub 2014 Feb 10. Review.

PMID:
24512271
8.

SGLT2-inhibitors: a novel class for the treatment of type 2 diabetes introduction of SGLT2-inhibitors in clinical practice.

Cuypers J, Mathieu C, Benhalima K.

Acta Clin Belg. 2013 Jul-Aug;68(4):287-93. Review.

PMID:
24455799
9.

[Sodium-glucose co-transporter-2 inhibitors: from the bark of apple trees and familial renal glycosuria to the treatment of type 2 diabetes mellitus].

Mauricio D.

Med Clin (Barc). 2013 Sep;141 Suppl 2:31-5. doi: 10.1016/S0025-7753(13)70061-7. Review. Spanish.

PMID:
24444522
10.

SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.

Jabbour SA.

Postgrad Med. 2014 Jan;126(1):111-7. doi: 10.3810/pgm.2014.01.2731. Review.

PMID:
24393758
11.

Drug-induced renal Fanconi syndrome.

Hall AM, Bass P, Unwin RJ.

QJM. 2014 Apr;107(4):261-9. doi: 10.1093/qjmed/hct258. Epub 2013 Dec 24. Review.

12.

Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?

Gilbert RE.

Kidney Int. 2014 Oct;86(4):693-700. doi: 10.1038/ki.2013.451. Epub 2013 Nov 20. Review.

PMID:
24257692
13.

The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus.

Riser Taylor S, Harris KB.

Pharmacotherapy. 2013 Sep;33(9):984-99. doi: 10.1002/phar.1303. Epub 2013 Jun 6. Review.

PMID:
23744749
14.

SGLT2 inhibition: a novel prospective strategy in treatment of diabetes mellitus.

Deshmukh AB, Patel MC, Mishra B.

Ren Fail. 2013;35(4):566-72. doi: 10.3109/0886022X.2013.766560. Epub 2013 Feb 25. Review.

PMID:
23438184
15.

SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus.

Misra M.

J Pharm Pharmacol. 2013 Mar;65(3):317-27. doi: 10.1111/j.2042-7158.2012.01574.x. Epub 2012 Aug 9. Review.

PMID:
23356840
16.

Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus.

Chen LH, Leung PS.

Diabetes Obes Metab. 2013 May;15(5):392-402. doi: 10.1111/dom.12064. Epub 2013 Feb 6. Review.

PMID:
23331516
17.

Sodium glucose cotransporter 2 and the diabetic kidney.

Komala MG, Panchapakesan U, Pollock C, Mather A.

Curr Opin Nephrol Hypertens. 2013 Jan;22(1):113-9. doi: 10.1097/MNH.0b013e32835a17ae. Review.

PMID:
23042029
18.

Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.

Abdul-Ghani MA, Norton L, Defronzo RA.

Endocr Rev. 2011 Aug;32(4):515-31. doi: 10.1210/er.2010-0029. Epub 2011 May 23. Review.

PMID:
21606218
19.

Biology of human sodium glucose transporters.

Wright EM, Loo DD, Hirayama BA.

Physiol Rev. 2011 Apr;91(2):733-94. doi: 10.1152/physrev.00055.2009. Review.

20.

Effect of kidney disease on glucose handling (including genetic defects).

Calado J, Santer R, Rueff J.

Kidney Int Suppl. 2011 Mar;(120):S7-13. doi: 10.1038/ki.2010.510. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk